NATCO Pharma begins phase-3 clinical trials of Molnupiravir capsules; Stock hits new all-time high

NATCO's Phase-III clinical trial is initiated to evaluate the efficacy and safety of Molnupiravir Capsules in mild COVID-19 patients.

from India Infoline News Service https://ift.tt/2ThP0Ud